NEWS
Protein Helps Predict Cancer Therapy-induced Heart Damage
In a prospective study of 251 women with HER2-positive breast cancer, women with elevated blood levels of a protein called troponin I had significantly higher rates of cardiotoxicity (heart damage) during treatment with trastuzumab (Herceptin) than women who did not have elevated levels of troponin I before or during treatment. Women with elevated troponin I were also three times less likely to recover from the observed heart damage. The results came from a study led by Dr. Daniela Cardinale of the European Institute of Oncology in Milan, Italy, and were published online August 2 in the Journal of Clinical Oncology. Read more > >
Bone Drugs Do Not Appear to Increase Esophageal or Gastric Cancer Risk
Cancer rates were similar for oral bisphosphonate users and nonusersImmune Cells’ Anticancer Abilities May Be Hampered by High Lipid Levels
Study suggests new way to enhance cancer immunotherapymicroRNA May Regulate Growth of Tumor Blood Vessels
Discovery could lead to strategies for blocking angiogenesisMany U.S. and Canadian Oncologists Unprepared to Use Cost-effectiveness Data in Practice
Survey shows similar opinions among oncologists in both countries
A MESSAGE TO READERS
NCI Cancer Bulletin Publication Break
The NCI Cancer Bulletin will not be published on August 24. Our next issue will be released on September 7, when we resume our usual biweekly publication schedule. If you are not yet a subscriber, please submit your e-mail address in the toolbox above to begin your free subscription.
IN DEPTH
A Cancer Treatment That Sticks Around
Animal studies set stage to test immunotherapy regimen in human trial
NCI’s Cancer Information Service: Providing Information and Assistance Nationwide
For 35 years, information specialists have answered the public’s questions about cancer
Featured Clinical Trial: Cediranib to Treat Alveolar Soft Part Sarcoma
Does experimental drug shrink tumors in patients with this disease?
The Comprehensive Cancer Center of Wake Forest University
The cancer center focuses on cancer issues that are important to communities in the region
UPDATES
Legislative Update
- Project Cancer Education: An Introduction to Translational Research at NCI
Cancer.gov Update
- NCI Recovery Act Web Site Highlights Cancer Disparity Studies
Notes
- NIH Intramural Research Program Is Recruiting Earl Stadtman Investigators
- Office of China Cancer Programs Issues Report on Symposium
- New Issue of OCG e-News Available
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit .
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
